Literature DB >> 23368432

Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer's disease patients of Northern Han Chinese descent.

Lin Bai1, Ning Song, Jintai Yu, Lan Tan, Yong Shen, Junxia Xie, Hong Jiang.   

Abstract

BACKGROUND: We recently reported elevated cerebrospinal fluid (CSF) levels of soluble tumor necrosis factor (TNF) receptors and TNF-α converting enzyme (TACE) activity in subjects with Alzheimer's disease (AD) in a Caucasian population. The TNF receptor-mediated signaling pathway contributes to the production of Aβ and the subsequent cytotoxicity that is observed in AD brains. However, whether the plasma levels of soluble TNF receptors (sTNFRs) are changed is still unclear in AD patients of Han descent.
METHODS: In the present study, we analyzed the plasma sTNFR levels using commercially available immunoassay kits in 76 AD patients and 40 age- and sex-matched control subjects of Northern Han Chinese descent. Furthermore, the TACE activity was measured using a solution-based assay containing a fluorescently labeled TACE substrate.
RESULTS: AD patients exhibited higher levels of both sTNFR and TACE activity in their plasma compared with age- and sex-matched control subjects. The levels of sTNFR1 strongly correlated with the levels of sTNFR2 (rs =0.526, P < 0.001). In addition, the levels of sTNFR1 were significantly correlated with TACE activity (rs = 0.308, P < 0.01).
CONCLUSION: These results suggest that sTNFRs and TACE activity might serve as potential peripheral diagnostic candidate biomarkers in AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23368432

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  8 in total

1.  sTNFr1 and it's contributory role in the evolution and progression of different psychiatric disorders.

Authors:  S Kapoor
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

2.  Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease.

Authors:  John A McIntyre; Curtis J Ramsey; Bruce D Gitter; Andrew J Saykin; Dawn R Wagenknecht; Paul A Hyslop
Journal:  Autoimmunity       Date:  2015-02-12       Impact factor: 2.815

Review 3.  Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer's Disease.

Authors:  Inmaculada Lopez-Font; Inmaculada Cuchillo-Ibañez; Aitana Sogorb-Esteve; María-Salud García-Ayllón; Javier Sáez-Valero
Journal:  Front Neurol       Date:  2015-06-02       Impact factor: 4.003

4.  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

5.  P2X7 Receptor Induces Tumor Necrosis Factor-α Converting Enzyme Activation and Release to Boost TNF-α Production.

Authors:  Maria Barberà-Cremades; Ana I Gómez; Alberto Baroja-Mazo; Laura Martínez-Alarcón; Carlos M Martínez; Carlos de Torre-Minguela; Pablo Pelegrín
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

6.  Identification of inflammatory and vascular markers associated with mild cognitive impairment.

Authors:  Xue-Ning Shen; Yanxia Lu; Crystal Tze Ying Tan; Ling-Yun Liu; Jin-Tai Yu; Lei Feng; Anis Larbi
Journal:  Aging (Albany NY)       Date:  2019-04-30       Impact factor: 5.682

7.  Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker.

Authors:  S-S Jiao; X-L Bu; Y-H Liu; Q-H Wang; C-H Liu; X-Q Yao; X-F Zhou; Y-J Wang
Journal:  Transl Psychiatry       Date:  2015-10-06       Impact factor: 6.222

8.  Levels of ADAM10 are reduced in Alzheimer's disease CSF.

Authors:  Aitana Sogorb-Esteve; María-Salud García-Ayllón; Johan Gobom; Jordi Alom; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  J Neuroinflammation       Date:  2018-07-25       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.